Displaying drugs 12601 - 12616 of 12616 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Zosuquidar | 527.616 C32H31F2N3O2 |  | Investigated for use/treatment in leukemia (myeloid) and myelodysplastic syndrome. | Drug Resistance, Multiple |
| Zotatifin | 487.556 C28H29N3O5 |  | Zotatifin is under investigation in clinical trial NCT04092673 (Study of Eft226 in Subjects With Selected Advanced Solid Tumor Malignancies). | Not Annotated |
| Zotepine | 331.86 C18H18ClNOS |  | Zotepine, like other atypical antipsychotics, is considered as the first-line treatment in newly diagnosed schizophrenia. It is usually thought to be an option of choice for managing acute schizophrenic episodes... | Neurotoxic agents |
| Zotiraciclib | 372.472 C23H24N4O |  | Zotiraciclib is under investigation in clinical trial NCT02942264 (Zotiraciclib (TG02) Plus Dose-dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in... | Cyclin-Dependent Kinases, antagonists & inhibitors |
| ZSTK-474 | 417.4125 C19H21F2N7O2 |  | ZSTK474 has been used in trials studying the treatment of Neoplasms. | Not Annotated |
| Zucapsaicin | 305.4119 C18H27NO3 |  | A topical analgesic used as an adjunct to relieve severe pain of osteoarthritis of the knee in selected adult patients. | Capsaicin and Similar Agents |
| Zuclopenthixol | 400.965 C22H25ClN2OS |  | An antipsychotic indicated for the management of schizophrenia. The acuphase formulation is indicated for initial treatment of acute psychosis or exacerbation of psychosis, while the depot formulation is best for maintenance. | Thioxanthene Derivatives |
| Zuranolone | 409.574 C25H35N3O2 |  | A neuroactive steroid drug used to treat postpartum depression | Central Nervous System Agents / Psychotropic Drugs |
| Zuretinol acetate | 328.4883 C22H32O2 |  | Zuretinol acetate has been used in trials studying the treatment of Impaired Dark Adaptation, RP (Retinitis Pigmentosa), Retinitis Pigmentosa (RP), and LCA (Leber Congenital Amaurosis). | Adjuvants, Immunologic / Anticarcinogenic Agents |
| ZY19489 | 465.581 C24H32FN9 |  | Not Annotated | Amines / Polyamines |
| ZYIL-1 | 403.54 C21H29N3O3S |  | Not Available | Not Available |
| Zytron | 314.16 C10H14Cl2NO2PS |  | Zytron (DMPA) is under investigation for the treatment and health services research of HIV, Lactation, Contraception, Postpartum Depression, and Immune Cells (Mucosal and Systemic). DMPA has been investigated for the... | Amines / Organophosphorus Compounds / Sulfur Compounds |
| α-Methylacetylfentanyl | 336.4705 C22H28N2O |  | α-Methylacetylfentanyl is an analog of fentanyl with opioid analgesic properties. It was categorized under the Schedule I in the US and it was illegally sold in early 1980. α-Methylacetylfentanyl synthesis... | Not Available |
| α-Methylfentanyl | 350.4971 C23H30N2O |  | α-Methylfentanyl is an analog of fentanyl with opioid analgesic properties. | Designer Drugs / Street Drugs |
| β-Hydroxythiofentanyl | 358.5 C20H26N2O2S |  | β-Hydroxythiofentanyl is an analgesic of the opioid class. This drug is an analog of fentanyl, a potent opioid. | Not Annotated |
| β-Methylfentanyl | 350.506 C23H30N2O |  | β-Methylfentanyl is an analgesic of the opioid class. It is an analog of the potent opioid, fentanyl. | Not Annotated |
Displaying drugs 12601 - 12616 of 12616 in total